Universal Health Services, issues upside guidance for FY09, sees EPS of $4.00-4.15 vs. $3.86 consensus; sees FY09 revs of $5.34 bln vs. $5.33 bln consensus.
(INT) - buy
World Fuel Services Corp, reported fourth-quarter results that beat market estimates, helped by rise in operating profits in its marine and aviation segments, and doubled its quarterly dividend.
(KSS) - short
Kohl's full-year outlook disappoints. Co issues downside guidance for Q1, sees EPS of $0.27-0.34 vs. $0.35 consensus; expects comps to be down 5-8% y/y.
(ITMN) - short
InterMune Inc, posted a wider quarterly loss on lower sales of its immune-boosting drug Actimmune, and forecast 2009 revenue well below market estimates.
(DECK) - short
Deckers Outdoor Corp, forecast 2009 profit well below market estimates. Co issues downside guidance for FY09, sees EPS of $7.27 vs. $8.05 consensus.
Woodward Governor cuts 2009 outlook. Co lowers FY09 EPS to $1.40-1.65, vs $1.75 First Call consensus. Co also lowers FY09 revs to $1.3 bln vs $1.46 bln First Call consensus.
(HMC) - short
Honda Motor Co, to cut output at home by over 150,000 units in the year from April, bringing its Japanese production below 1 million vehicles for the first time in 14 years.
(DVA) - short
DaVita discloses that it is the subject of a number of inquiries by the federal government. Any negative findings could result in substantial financial penalties, exclusion from future participation in the Medicare programs and, criminal penalties.
(RRD) - short
Standard & Poor's Ratings Services said it is considering downgrading ratings for R.R. Donnelley & Sons Co., based on fears about the company's performance in 2009 through the economic downturn.
(HBC) - short
HSBC Holdings is going to announce plans Monday to raise at least ($17.18 billion) in fresh capital and cut its dividend, according to people familiar with the situation. Even banks that have until now remained healthy are getting hit by the global downturn.
Alcon, Inc, the world’s leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its aspheric AcrySof® IQ Toric intraocular lens (IOL)
(SYKE) - short
Sykes Enterprises 4Q profit drops 19 percent. Co issues downside guidance for Q1, sees EPS of $0.28-0.30 vs. $0.32 consensus; sees Q1 revs of $203 mln vs. $205.86 mln consensus.
(MDR) - short
McDermott 4th-qtr profit down sharply. Fourth-quarter profit fell to $43 mln, or 19 cents per share, from $160 mln, or 70 cents per share, a year before.
(GENZ) - short
Genzyme's Lumizyme faces delay after FDA rejection.
(FELE) - short
Franklin Electric posts lower-than-expected Q4 results.
Wilson Greatbatch beats by $0.13, beats on revs; guides FY09 revs in-line.
(MASI) - buy
Masimo Q4 results top estimates. Total revenue rose 20 percent to $83.1 million.
(DEO) - short
Diageo plc to cut 4% of North American workers - WSJ
(PALM) - short
Palm Inc warned of weaker-than-expected quarterly revenue due to lower demand for its older phones, a weak economy and late U.S. shipments of its Treo Pro.
(URS) - short
URS gives weak outlook. Co also issues mixed guidance for FY09, sees EPS of $2.80 vs. $2.95 consensus; sees FY09 revs of $9.5 bln vs. $10.35 bln consensus.
Weight Watchers Q4 profit beats estimates. Co reported a fourth-quarter net income of $47.6 mln, or 62 cents per share, compared with $39.8 mln, or 50 cents per share, a year ago.
(SIGM) - buy
Sigma Designs profit tops estimates. Co Q4 adj EPS was $0.38 vs est $0.18.
(PETM) - buy
PetSmart Inc. said that its fourth-quarter profit rose to $78.4 mln, or 62 cents a share, from $75.4 mln, or 59 cents a share, in the year-ago period. Revenue rose to $1.36 bln from $1.33 bln last year.
(GYMB) - short
Gymboree gives bleak Q1 outlook. Co issues downside guidance for Q1, sees EPS of $0.18-0.25 vs. $0.76 consensus.
(FPIC) - short
FPIC Insurance reports Q4 net income per share of $0.55 vs $1.17 First Call consensus.
Cooper, fiscal 1Q profit surges. Company earned $23.9 mln, or 53 cents per share, for the quarter ended Jan. 31, compared with net income of $6.9 mln, or 15 cents per share, during the same period a year prior.
(ARST) - buy
ArcSight, Q3 profit beats Street, sees strong Q4. Co issues upside guidance for FY09, sees EPS of $0.41-0.48 vs. $0.29 consensus; sees FY09 revs of $130.9-134.9 vs. $127.34 mln consensus.
(IPI) - short
Intrepid Potash, earnings preview. IPI has a short history as the IPO was issued in April of 2008. Since then, the co missed by $0.07 in the most recent quarter (Q3). The current quarter provides more uncertainty following the reduction in sales by 50%.
(EBS) - short
Emergent BioSolutions, 4Q profit plunges. Company set its revenue outlook well below Wall Street forecasts.
(SEPR) - short
Sepracor, reports preliminary Phase II study results for SEP-225441 for the treatment of generalized anxiety disorder, did not meet its primary efficacy endpoint.
Traders experienced a lack luster day in trading today, as we get off another new week in March. The deal between Merck and Schering-Plough got attention as well as, the deal with Dow Chemical and Rohm & Haas. Merger Monday as it was once known, before the economic downturn began, quite some time ago.
Free Daily Stock Picks activity and results for March 9, 2009:
GERN - position entry at 5.19, Stop Loss Level hit for a loss of 0.50 point
STEM - position entry at 2.25, 3rd Target Level hit for a gain of 0.13 points
CYTX - position entry at 3.30, Stop Loss Level hit for a loss of 0.50 points
CUR - position entry at 1.40, 3rd Target Level hit for a gain of 0.08 points
ASTM - position entry at 0.63, 3rd Target Level hit for a gain of 0.04 points
Get instant entry alerts for the Free Daily Stock Picks at Zantrio:
(UHS) - buy
Universal Health Services, issues upside guidance for FY09, sees EPS of $4.00-4.15 vs. $3.86 consensus; sees FY09 revs of $5.34 bln vs. $5.33 bln consensus.
(INT) - buy
World Fuel Services Corp, reported fourth-quarter results that beat market estimates, helped by rise in operating profits in its marine and aviation segments, and doubled its quarterly dividend.
(KSS) - short
Kohl's full-year outlook disappoints. Co issues downside guidance for Q1, sees EPS of $0.27-0.34 vs. $0.35 consensus; expects comps to be down 5-8% y/y.
(ITMN) - short
InterMune Inc, posted a wider quarterly loss on lower sales of its immune-boosting drug Actimmune, and forecast 2009 revenue well below market estimates.
(DECK) - short
Deckers Outdoor Corp, forecast 2009 profit well below market estimates. Co issues downside guidance for FY09, sees EPS of $7.27 vs. $8.05 consensus.
(WGOV) - short
Woodward Governor cuts 2009 outlook. Co lowers FY09 EPS to $1.40-1.65, vs $1.75 First Call consensus. Co also lowers FY09 revs to $1.3 bln vs $1.46 bln First Call consensus.
(HMC) - short
Honda Motor Co, to cut output at home by over 150,000 units in the year from April, bringing its Japanese production below 1 million vehicles for the first time in 14 years.
(DVA) - short
DaVita discloses that it is the subject of a number of inquiries by the federal government. Any negative findings could result in substantial financial penalties, exclusion from future participation in the Medicare programs and, criminal penalties.
(RRD) - short
Standard & Poor's Ratings Services said it is considering downgrading ratings for R.R. Donnelley & Sons Co., based on fears about the company's performance in 2009 through the economic downturn.
(HBC) - short
HSBC Holdings is going to announce plans Monday to raise at least ($17.18 billion) in fresh capital and cut its dividend, according to people familiar with the situation. Even banks that have until now remained healthy are getting hit by the global downturn.
(ACL) - buy
Alcon, Inc, the world’s leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its aspheric AcrySof® IQ Toric intraocular lens (IOL)
(SYKE) - short
Sykes Enterprises 4Q profit drops 19 percent. Co issues downside guidance for Q1, sees EPS of $0.28-0.30 vs. $0.32 consensus; sees Q1 revs of $203 mln vs. $205.86 mln consensus.
(MDR) - short
McDermott 4th-qtr profit down sharply. Fourth-quarter profit fell to $43 mln, or 19 cents per share, from $160 mln, or 70 cents per share, a year before.
(GENZ) - short
Genzyme's Lumizyme faces delay after FDA rejection.
(FELE) - short
Franklin Electric posts lower-than-expected Q4 results.
(GB) - buy
Wilson Greatbatch beats by $0.13, beats on revs; guides FY09 revs in-line.
(MASI) - buy
Masimo Q4 results top estimates. Total revenue rose 20 percent to $83.1 million.
(DEO) - short
Diageo plc to cut 4% of North American workers - WSJ
(PALM) - short
Palm Inc warned of weaker-than-expected quarterly revenue due to lower demand for its older phones, a weak economy and late U.S. shipments of its Treo Pro.
(URS) - short
URS gives weak outlook. Co also issues mixed guidance for FY09, sees EPS of $2.80 vs. $2.95 consensus; sees FY09 revs of $9.5 bln vs. $10.35 bln consensus.
(WTW) - buy
Weight Watchers Q4 profit beats estimates. Co reported a fourth-quarter net income of $47.6 mln, or 62 cents per share, compared with $39.8 mln, or 50 cents per share, a year ago.
(SIGM) - buy
Sigma Designs profit tops estimates. Co Q4 adj EPS was $0.38 vs est $0.18.
(PETM) - buy
PetSmart Inc. said that its fourth-quarter profit rose to $78.4 mln, or 62 cents a share, from $75.4 mln, or 59 cents a share, in the year-ago period. Revenue rose to $1.36 bln from $1.33 bln last year.
(GYMB) - short
Gymboree gives bleak Q1 outlook. Co issues downside guidance for Q1, sees EPS of $0.18-0.25 vs. $0.76 consensus.
(FPIC) - short
FPIC Insurance reports Q4 net income per share of $0.55 vs $1.17 First Call consensus.
(COO) - buy
Cooper, fiscal 1Q profit surges. Company earned $23.9 mln, or 53 cents per share, for the quarter ended Jan. 31, compared with net income of $6.9 mln, or 15 cents per share, during the same period a year prior.
(ARST) - buy
ArcSight, Q3 profit beats Street, sees strong Q4. Co issues upside guidance for FY09, sees EPS of $0.41-0.48 vs. $0.29 consensus; sees FY09 revs of $130.9-134.9 vs. $127.34 mln consensus.
(IPI) - short
Intrepid Potash, earnings preview. IPI has a short history as the IPO was issued in April of 2008. Since then, the co missed by $0.07 in the most recent quarter (Q3). The current quarter provides more uncertainty following the reduction in sales by 50%.
(EBS) - short
Emergent BioSolutions, 4Q profit plunges. Company set its revenue outlook well below Wall Street forecasts.
(SEPR) - short
Sepracor, reports preliminary Phase II study results for SEP-225441 for the treatment of generalized anxiety disorder, did not meet its primary efficacy endpoint.
(GERN) - buy
Obama will lift stem cell research funding ban on Monday.
(STEM) - buy
Obama will lift stem cell research funding ban on Monday.
(CYTX) - buy
Obama will lift stem cell research funding ban on Monday.
(CUR) - buy
Obama will lift stem cell research funding ban on Monday.
(ASTM) - buy
Obama will lift stem cell research funding ban on Monday.
Get instant entry alerts for the Free Daily Stock Picks at Zantrio:
Stock Picks - Zantrio
Detailed performance on the Free Daily Stock Picks at Zantrio:
Stock Picks Peformance - Zantrio
Traders experienced a lack luster day in trading today, as we get off another new week in March. The deal between Merck and Schering-Plough got attention as well as, the deal with Dow Chemical and Rohm & Haas. Merger Monday as it was once known, before the economic downturn began, quite some time ago.
Free Daily Stock Picks activity and results for March 9, 2009:
GERN - position entry at 5.19, Stop Loss Level hit for a loss of 0.50 point
STEM - position entry at 2.25, 3rd Target Level hit for a gain of 0.13 points
CYTX - position entry at 3.30, Stop Loss Level hit for a loss of 0.50 points
CUR - position entry at 1.40, 3rd Target Level hit for a gain of 0.08 points
ASTM - position entry at 0.63, 3rd Target Level hit for a gain of 0.04 points
Get instant entry alerts for the Free Daily Stock Picks at Zantrio:
Stock Picks - Zantrio
Detailed performance on the Free Daily Stock Picks at Zantrio:
Stock Picks Peformance - Zantrio